# SensifAI Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sensifai-health

- Industry: Software
- Headquarters: Montreal, Canada
- Website: www.sensifai.health
- Latest round: Seed (Jul 2, 2025)
- Investors on record: 2

## About

Based in Montreal, Canada, SensifAI Health Inc. specializes in advanced predictive health technologies using artificial intelligence (AI) to monitor immune system activity, aiming to improve patient health outcomes.SensifAI Health Inc. was founded in 2023 and operates out of Montreal, Canada. The company focuses on leveraging AI for health monitoring and has completed one deal as of July 2025. The firm does not have any known subsidiaries or parent companies. There is no information indicating changes in business strategy or operations since its inception.SensifAI Health specializes in advanced predictive health technologies that utilize artificial intelligence (AI) to monitor and analyze immune system activity in individuals. Their primary offering includes AI-powered inflammation detection technology that integrates seamlessly with off-the-shelf wearable devices, enabling early identification of inflammation patterns and correlating physiological signals with personalized inflammation scores. This facilitates timely interventions before clinical complications arise. SensifAI's platform serves healthcare systems, pharmaceutical companies, and digital health platforms, focusing on optimizing health outcomes for high-risk patients and broader populations. The solutions are marketed primarily in North America and Europe, targeting healthcare providers and patients benefiting from proactive health monitoring and intervention strategies.SensifAI Health generates revenue through partnerships and collaborations with healthcare providers, pharmaceutical companies, and wearable device manufacturers. The revenue model is structured around B2B transactions, where clients integrate SensifAI's AI technology into their existing systems and services, enabling proactive health management. Partnerships may involve licensing agreements or subscription-based arrangements, allowing clients to access SensifAI's predictive capabilities on an ongoing basis. Specific pricing details for the services provided are not publicly disclosed, but the firm focuses on delivering a comprehensive platform that enhances clinical care through predictive analytics and early intervention strategies, positioning SensifAI Health as a crucial partner for organizations aiming to improve patient outcomes and reduce healthcare costs associated with preventable exacerbations of respiratory infections and other health complications.In July 2025, SensifAI Health Inc. raised an undisclosed amount of Seed funding led by Glen Ventures. The company plans to utilize this funding to support its expansion plans, which may include the development and launch of new products designed to enhance its AI capabilities in health monitoring. SensifAI Health is also focusing on expanding its market presence in North America and Europe, targeting new healthcare providers and digital health platforms to integrate its services. The funding aims to drive these initiatives and support further growth in the upcoming years.

## Funding rounds

- Seed, Jul 2, 2025 — Investment Quebec, Glen Ventures

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- Glen Ventures (https://capitalatlas.ai/funds/glen-ventures) — Seed